News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Moderna says new data indicates its COVID-19 vaccine offers protection against emerging variants, including the seemingly fast spreading Delta variant, first identified in India.
The New York based company said the deal will expand its in vitro diagnostic, cell and gene therapy support capabilities.
Simcere has announced a partnership with Vivoryon whereby it will leverage the potential of innovative N3pE amyloid-targeting agents to treat Alzheimer’s disease (AD) in Greater China.
The company publishes results showing positive preliminary data for its islet cell replacement therapy for type 1 diabetes.
The agency allows fill-finish activities for Janssen’s COVID-19 vaccine to take place at Catalent’s Italian site.